Pharmaron Beijing Co (HKSE:03759) Margin of Safety % (DCF Earnings Based): 36.60% (As of Jul. 06, 2026)


HKSE:03759 Pharmaron Beijing Co Ltd HKSE:03759
95 GF Score
Price HK$20.58
GF Value HK$22.58
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Pharmaron Beijing Co Margin of Safety % (DCF Earnings Based)?

Pharmaron Beijing Co HKSE:03759 +5.43% 95 Margin of Safety % (DCF Earnings Based) is 36.60% as of Jul. 06, 2026. GuruFocus rates HKSE:03759 with a GF Score™ of 95/100 and a GF Value™ of HK$22.58 (Fairly Valued). The stock has 4 warning signs investors should review.

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2026-07-06), Pharmaron Beijing Co's Predictability Rank is 2.5-Stars. Pharmaron Beijing Co's intrinsic value calculated from the Discounted Earnings model is HK$32.46 and current share price is HK$20.58. Consequently,

Pharmaron Beijing Co's Margin of Safety % (DCF Earnings Based) using Discounted Earnings model is 36.60%.

HKSE:03759 vs VRTX, REGN, ALNY: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Pharmaron Beijing Co's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmaron Beijing Co Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmaron Beijing Co's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Pharmaron Beijing Co's Margin of Safety % (DCF Earnings Based) falls into.


HKSE:03759
95GF Score
Pharmaron Beijing Co Ltd HKSE:03759
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharmaron Beijing Co Margin of Safety % (DCF Earnings Based) Calculation

Pharmaron Beijing Co's Margin of Safety % (DCF Earnings Based) for today is calculated as

Margin of Safety % (DCF Earnings Based)=(Intrinsic Value: DCF (Earnings Based)-Current Price)/Intrinsic Value: DCF (Earnings Based)
=(32.46-20.58)/32.46
=36.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Earnings model with default parameters. The calculation method is the same as Discounted Cash Flow model except earnings are used in the calculation instead of free cash flow.

What does a Margin of Safety % (DCF Earnings Based) of 36.60% mean?
Pharmaron Beijing Co (HKSE:03759) has a Margin of Safety % (DCF Earnings Based) of 36.60% as of Jul. 06, 2026. Margin of Safety % (DCF Earnings Based) is the percent difference between the current price and the intrinsic DCF Earnings price. View historical data on Pharmaron Beijing Co.
Is Pharmaron Beijing Co's Margin of Safety % (DCF Earnings Based) too high?
Pharmaron Beijing Co's current Margin of Safety % (DCF Earnings Based) is 36.60%. Overall, Pharmaron Beijing Co has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pharmaron Beijing Co's Margin of Safety % (DCF Earnings Based) compare to VRTX and REGN?
Pharmaron Beijing Co's Margin of Safety % (DCF Earnings Based) of 36.60% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Margin of Safety % (DCF Earnings Based) for a Biotechnology company?
A good Margin of Safety % (DCF Earnings Based) depends on the Biotechnology industry context. However, Margin of Safety % (DCF Earnings Based) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Margin of Safety % (DCF Earnings Based) mean?
A high Margin of Safety % (DCF Earnings Based) can signal that a stock is expensive relative to its fundamentals. Margin of Safety % (DCF Earnings Based) is the percent difference between the current price and the intrinsic DCF Earnings price. View historical data on Pharmaron Beijing Co. Pharmaron Beijing Co's current Margin of Safety % (DCF Earnings Based) is 36.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaron Beijing Co stock overvalued right now?
Based on GuruFocus' analysis, Pharmaron Beijing Co (HKSE:03759) is currently considered Fairly Valued. The stock's GF Value™ is HK$22.58, compared to a current price of HK$20.58 — trading 8.9% below its estimated fair value. The current Margin of Safety % (DCF Earnings Based) is 36.60%. Pharmaron Beijing Co's overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Margin of Safety % (DCF Earnings Based) calculated?
Margin of Safety % (DCF Earnings Based) is calculated from a company's financial statements. For Pharmaron Beijing Co (HKSE:03759), the current Margin of Safety % (DCF Earnings Based) is 36.60% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharmaron Beijing Co (HKSE:03759) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmaron Beijing Co stock appears to be undervalued. The current stock price of HK$20.58 is trading 8.9% below its estimated GF Value™ of HK$22.58. GuruFocus considers Pharmaron Beijing Co to be Fairly Valued.

Key valuation signals for HKSE:03759:

  • Margin of Safety % (DCF Earnings Based): 36.60%
  • GF Value™: HK$22.58 vs. price of HK$20.58 (8.9% below fair value)
  • GF Score™: 95/100 with 4 warning signs

No single metric tells the full story. See the HKSE:03759 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharmaron Beijing Co Business Description

Other Exchanges 17Q1:Germany300759:China
Address 6 Tai-He Road, 8th Floor, Block 1, Beijing Economic Technological Development Area, Beijing, CHN, 100176
Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal, and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry, and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. Its operating segment includes Laboratory services; CMC (small molecule CDMO) services, Clinical development services, and biologics and CGT services. It generates maximum revenue from the Laboratory services segment.
95GF Score

Get the complete analysis for HKSE:03759

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$20.58
Price
HK$22.58
GF Value